These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Oral anticoagulant therapy with special reference to the influence of food and drug interactions]. Aosaki M. Kokyu To Junkan; 1991 Aug; 39(8):779-88. PubMed ID: 1681576 [No Abstract] [Full Text] [Related]
8. [Mechanism of action of vitamin K and how it is affected by anticoagulants]. Schade R, Janowski K. Pharmazie; 1976 Aug; 31(9):585-9. PubMed ID: 798207 [No Abstract] [Full Text] [Related]
9. The pharmacodynamics of the oral anticoagulant drugs. O'Reilly RA. Prog Hemost Thromb; 1974 Aug; 2(0):175-213. PubMed ID: 4137288 [No Abstract] [Full Text] [Related]
16. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9. He M, Korzekwa KR, Jones JP, Rettie AE, Trager WF. Arch Biochem Biophys; 1999 Dec 01; 372(1):16-28. PubMed ID: 10562412 [Abstract] [Full Text] [Related]
17. Vitamin K requirement in Danish anticoagulant-resistant Norway rats (Rattus norvegicus). Markussen MD, Heiberg AC, Nielsen R, Leirs H. Pest Manag Sci; 2003 Aug 01; 59(8):913-20. PubMed ID: 12916772 [Abstract] [Full Text] [Related]
18. The pharmacology of oral anticoagulants: implications for therapy. Shetty HG, Woods F, Routledge PA. J Heart Valve Dis; 1993 Jan 01; 2(1):53-62. PubMed ID: 8269110 [Abstract] [Full Text] [Related]
19. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats. Ren P, Laliberte RE, Bell RG. Mol Pharmacol; 1974 May 01; 10(3):373-80. PubMed ID: 4851787 [No Abstract] [Full Text] [Related]
20. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions. Wittkowsky AK. Semin Vasc Med; 2003 Aug 01; 3(3):221-30. PubMed ID: 15199454 [Abstract] [Full Text] [Related] Page: [Next] [New Search]